Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)
China flag China · Delayed Price · Currency is CNY
9.91
-0.26 (-2.56%)
May 12, 2026, 3:04 PM CST

SHE:002873 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
734.28748.82856.87953.261,087968.7
Other Revenue
0.90.90.670.730.881.15
735.18749.72857.55953.981,088969.84
Revenue Growth (YoY)
-15.82%-12.57%-10.11%-12.29%12.15%29.15%
Cost of Revenue
210.66216.67230.72219.39247.65201.16
Gross Profit
524.52533.05626.83734.59840.02768.69
Selling, General & Admin
446.58456.71513.64589.02673.99606.18
Research & Development
42.7142.5540.4738.1321.5820.38
Other Operating Expenses
13.7312.311210.5413.1713.81
Operating Expenses
501.63510.19568.72637.42709.27642.1
Operating Income
22.8922.8658.1197.17130.75126.58
Interest Expense
-17.76-17.76-17.57-11.8-10.67-16.6
Interest & Investment Income
0.420.420.670.920.731.37
Currency Exchange Gain (Loss)
---0--
Other Non Operating Income (Expenses)
2.160.31-0.051.92-5.41-2.93
EBT Excluding Unusual Items
7.715.8341.1688.21115.39108.42
Gain (Loss) on Sale of Investments
-0.02-0.020.02-0.72-0.4-
Gain (Loss) on Sale of Assets
-0.85-0.7818.9--0.02-0.1
Asset Writedown
-1.2-0.16-0.71-0.07-0.12-0.37
Other Unusual Items
4.94.91.3856.488.69
Pretax Income
10.549.7760.7692.42121.34116.65
Income Tax Expense
2.120.668.4311.559.8316.04
Earnings From Continuing Operations
8.429.1152.3280.87111.52100.61
Net Income
8.429.1152.3280.87111.52100.61
Net Income to Common
8.429.1152.3280.87111.52100.61
Net Income Growth
-79.43%-82.59%-35.30%-27.48%10.85%35.76%
Shares Outstanding (Basic)
236235220232232227
Shares Outstanding (Diluted)
236235220245244245
Shares Change (YoY)
5.53%6.87%-9.91%0.41%-0.41%1.34%
EPS (Basic)
0.040.040.240.350.480.44
EPS (Diluted)
0.040.040.240.330.460.41
EPS Growth
-80.51%-83.70%-28.18%-27.78%11.30%33.96%
Free Cash Flow
51.2932.1426.68-23.92-53.3818.61
Free Cash Flow Per Share
0.220.140.12-0.10-0.220.08
Dividend Per Share
0.0300.0300.1000.0700.1000.086
Dividend Growth
-70.00%-70.00%42.86%-30.00%16.69%40.03%
Gross Margin
71.35%71.10%73.10%77.00%77.23%79.26%
Operating Margin
3.11%3.05%6.78%10.19%12.02%13.05%
Profit Margin
1.15%1.21%6.10%8.48%10.25%10.37%
Free Cash Flow Margin
6.98%4.29%3.11%-2.51%-4.91%1.92%
EBITDA
55.9255.7490.4117.51155.38148.33
EBITDA Margin
7.61%7.43%10.54%12.32%14.29%15.29%
D&A For EBITDA
33.0332.8832.2920.3424.6421.74
EBIT
22.8922.8658.1197.17130.75126.58
EBIT Margin
3.11%3.05%6.78%10.19%12.02%13.05%
Effective Tax Rate
20.15%6.73%13.88%12.49%8.10%13.75%
Revenue as Reported
749.72749.72857.55953.981,088969.84
Advertising Expenses
-13.0916.5743.4643.15-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.